Additionally, single nucleotide polymorphisms (SNPs) within the IFNG gene have been associated with the expansion and proliferation of hematopoietic stem cells, influencing the response to imatinib therapy in patients diagnosed with chronic myeloid leukemia (CML) [74]. This evidence concerns the gene IFNG and chronic myelogenous leukemia, BCR-ABL1 positive.